作者:Wieslaw M. Kazmierski、Eric Furfine、Andrew Spaltenstein、Lois L. Wright
DOI:10.1016/j.bmcl.2006.07.014
日期:2006.10
morpholinone-based cyclic mimetics of the P1/P2 portion of the HIV-1 protease inhibitor Amprenavir. This effort led to discovery of allyl- and spiro-cyclopropyl-P2-substituted inhibitors 17 and 31, both 500 times more potent than the parent inhibitor 1. These results support morpholinones as novel mimetics of the P1/P2 portion of Amprenavir and potentially of other HIV-protease inhibitors, and thus provide
我们已经开发了HIV-1蛋白酶抑制剂Amprenavir的P1 / P2部分基于吗啉酮的环状模拟物的有效合成。这项工作导致发现了烯丙基-和螺环丙基-P2-取代的抑制剂17和31,两者的活性都比母体抑制剂1高500倍。这些结果支持吗啉酮作为Amprenavir P1 / P2部分的新型模拟物,并可能其他HIV蛋白酶抑制剂,因此提供了一种新颖的药物化学模板,可优化针对更有效和类似药物的抑制剂。